Sunday, September 24, 2023
Therapeutic Advances in PPD and MDD:
Postpartum depression (PPD) and major depressive disorder (MDD) are common, pervasive, and frequently severe and debilitating mental disorders. Screening rates for PPD are low and this disorder often remains undiagnosed. Assessment, diagnosis, and the appropriate treatment are key in managing patients with PPD. Patients with MDD often fail standard therapies or experience side effects resulting in nonadherence. New and emerging treatment strategies for PPD and MDD may offer more effective management for patients with these conditions. Join us on this page for CME activities, resources, and to share your insights with colleagues via the polling feature.
Supported by an independent educational grant from
Sage Therapeutics Inc.
See All
Steering Committee Chair
Associate Professor
Director
UNC Perinatal Psychiatry Program
UNC Center for Women's Mood Disorders
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Associate Professor of Psychiatry
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts
Associate Professor
UMass Medical School
Medical Director
Massachusetts Child Psychiatry Access Project for Moms
UMass Memorial Medical Center
Worcester, Massachusetts
David C. Wilson Professor and Chair
Department of Psychiatry and Neurobehavioral Sciences
University of Virginia
Charlottesville, Virginia
Chief Medical Officer
Atrium Health Pineville
Maternal Fetal Medicine
Atrium Health
Carolinas Healthcare System Pineville
Pineville, North Carolina
Professor of Psychiatry and Pharmacology
University Health Network
University of Toronto
Toronto, Ontario, Canada
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Cala Health, Inc.
Received grants for clinical research from: Janssen Pharmaceuticals; Sage Therapeutics, Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Received grants for clinical research from: JayMac Pharmaceuticals, LLC; Sage Therapeutics, Inc
Served as an advisor or consultant for: Alkermes, Inc; Otuska Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.
Other: Independent Data Safety and Monitoring Committee for Janssen Pharmaceuticals (Johnson & Johnson Pharmaceutical Research & Development, L.L.C.); Works with the MGH National Pregnancy Registry with current registry sponsors of Alkermes, Inc.; Forest/Actavis; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals Inc.; Teva Pharmaceuticals
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Mathematica Policy Research; Ovia Health; Sage Therapeutics, Inc
Served as a speaker or a member of a speakers bureau for: Sage Therapeutics, Inc.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: ACADIA Pharmaceuticals Inc.; Alkermes, Inc.; Allergan, Inc.; AMAG Pharmaceuticals, Inc.; Fabre-Kramer Pharmaceuticals, Inc.; Lundbeck, Inc.; Palatin Technologies, Inc.; S1 Biopharma, Inc.; Sage Therapeutics, Inc.; Sprout Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.
Received grants for clinical research from: Endoceutics, Inc.; Janssen Pharmaceuticals; Sage Therapeutics, Inc.; Takeda Pharmaceuticals North America, Inc.
Owns stock, stock options, or bonds from: Euthymics Bioscience, Inc.; S1 Biopharma, Inc.
Steering Committee Member
Has has disclosed no relevant financial relationships.
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Allergan, Inc.; Janssen Pharmaceuticals; Lundbeck, Inc.; Minerva Neurosciences; Neurocrine Biosciences, Inc.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Purdue Pharma L.P.; Shire; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals North America, Inc.
Served as a speaker or a member of a speakers bureau for: Allergan, Inc.; Janssen Pharmaceuticals; Lundbeck, Inc.; Minerva Neurosciences; Neurocrine Biosciences, Inc.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Purdue Pharma L.P.; Shire; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals North America, Inc.
Received grants for clinical research from: CIHR/GACD/Chinese National Natural Research Foundation; Stanley Medical Research Institute